Shape Therapeutics Funding & Investors
Seattle, WA
Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible.
shapetx.comTotal Amount Raised: $147,500,000
Shape Therapeutics Funding Rounds
Series B
$112,000,000
Series B Investors
Breton Capital ManagementDecheng CapitalWillett AdvisorsMission BioCapitalNew Enterprise Associates (NEA)Ling WongSeries A
$35,500,000
Series A Investors
New Enterprise Associates (NEA)CureDuchenne VenturesTectonic CapitalMission BioCapitalLing Wong
Funding info provided by Diffbot.